People in intensive care with <scp>COVID</scp> ‐19: demographic and clinical features during the first, second, and third pandemic waves in Australia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

People in intensive care with COVID ‐19: demographic and clinical features during the first, second, and third pandemic waves in Australia

Published:2022-06-09 Issue:7 Volume:217 Page:352-360
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Begum Husna¹,Neto Ary S²,Alliegro Patricia³,Broadley Tessa¹,Trapani Tony¹³,Campbell Lewis T⁴⁵,Cheng Allen C¹^ORCID,Cheung Winston⁶,Cooper D James¹²³,Erickson Simon J⁷,French Craig J⁸,Litton Edward⁹,McAllister Richard¹⁰,Nichol Alistair¹³,Palermo Annamaria⁹¹¹,Plummer Mark P¹²,Rotherham Hannah¹²^ORCID,Ramanan Mahesh¹³¹⁴^ORCID,Reddi Benjamin¹⁵,Reynolds Claire¹⁶,Webb Steven AR¹⁷,Udy Andrew A¹²,Burrell Aidan³

Affiliation:

1. Monash University Melbourne VIC

2. Australian and New Zealand Intensive Care Research Centre Melbourne VIC

3. Alfred Health Melbourne VIC

4. Royal Darwin Hospital Darwin NT

5. Menzies School of Health Research Darwin NT

6. Concord Repatriation General Hospital Sydney NSW

7. Princess Margaret Hospital for Children Perth WA

8. Western Heath Melbourne VIC

9. Fiona Stanley Hospital Perth WA

10. Royal Hobart Hospital Hobart TAS

11. St John of God Health Care Perth WA

12. Royal Melbourne Hospital Melbourne VIC

13. Prince Charles Hospital Brisbane QLD

14. Caboolture Hospital Caboolture QLD

15. Royal Adelaide Hospital Adelaide SA

16. St Vincent's Hospital Sydney NSW

17. University of Western Australia Perth WA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.51590

Reference28 articles.

1. An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19

2. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

3. Characteristics and outcomes of an international cohort of 400,000 hospitalised patients with Covid-19

4. Understanding how Victoria, Australia gained control of its second COVID-19 wave

5. Early analysis of the Australian COVID-19 epidemic

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of acute hypoxaemic respiratory failure in Australian and New Zealand intensive care units during 2005–2022. A binational, registry-based study;Intensive Care Medicine;2024-09-02

2. COVID-19 hospitalisations in a tertiary health service during the Omicron subvariant wave;Australian and New Zealand Journal of Public Health;2024-08

3. Prevalence, risk factors, and outcomes of secondary infections among hospitalized patients with COVID-19 or post–COVID-19 conditions in Victoria, 2020-2023;International Journal of Infectious Diseases;2024-08

4. COVID-19 in a rural intensive care unit in Northern British Columbia: Descriptive analysis of outcomes and demands on rural resources;Canadian Journal of Rural Medicine;2024-07

5. Cardiovascular outcomes for people hospitalised with COVID‐19 in Australia, and the effect of vaccination: an observational cohort study;Medical Journal of Australia;2024-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3